Institut Bergonié

Bordeaux, Aquitaine 33076

1 studies enrolling now · 5 studies all time

What they study most

EBV Related PTCL, NOS, EBV-Positive DLBCL, NOS, EBV-Related Hodgkin Lymphoma, EBV-Related Lymphoproliferative Disorder, EBV-Related Non-Hodgkin Lymphoma, EBV-Related PTLD, Epstein-Barr Virus Associated Lymphoma, Indolent Non-Hodgkin's Lymphomas, Mild Thrombocytopenia, Moderate Thrombocytopenia, Myelofibrosis, Neoplasm Metastasis

Studies at this site

• A Study of Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopenia — Recruiting now
• Study of Selinexor in Combination With Ruxolitinib in Myelofibrosis — Running, not enrolling
• An Open-Label Phase 2 Trial of Nanatinostat Plus Valganciclovir in Patients With EBV+ Relapsed/Refractory Lymphomas — Stopped early
• Study of Cryoablation for Metastatic Lung Tumors — Completed
• Efficacy and Safety of Idelalisib (GS-1101) in Combination With Bendamustine and Rituximab for Previously Treated Indolent Non-Hodgkin Lymphomas — Stopped early